Association between high dose catecholamine support and liver dysfunction following cardiac surgery.

Area of Science:

• Cardiology
• Hepatology
• Anesthesiology

Background:

• Cardiac surgery often requires cardiopulmonary bypass.
• 20-30% of patients need vasopressors post-surgery, increasing organ dysfunction and mortality risks.
• Nonalcoholic fatty liver disease (NAFLD) is common in these patients and may contribute to cardiac issues.

Purpose of the Study:

• To investigate the association between NAFLD and the need for vasopressor/inotropic support after cardiac surgery.
• To identify risk factors for vasopressor dependency in cardiac surgery patients with NAFLD.

Main Methods:

• Retrospective analysis of 463 patients undergoing elective cardiac surgery.
• NAFLD diagnosed using the NAFLD fibrosis score.
• Vasoactive-inotropy score used to assess vasopressor and inotropic dependency.

Main Results:

• Patients with NAFLD showed significantly higher vasopressor/inotropic support needs post-surgery.
• NAFLD was an independent predictor of high vasopressor/inotropic support, alongside other factors like ejection fraction and MELD score.
• NAFLD patients experienced more organ dysfunction, dialysis dependency, and longer ICU/hospital stays, with the highest mortality in those with high catecholamine support.

Conclusions:

• NAFLD is prevalent in cardiac surgery patients.
• Anesthesiologists and intensivists must recognize the unique risks associated with NAFLD in this population.